Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 3 of 3 entries
Sorted by: Best Match Show Resources per page
Progression from subclinical inflammation to overt SpA in first degree relatives of SpA patients is associated with HLA-B27: the Pre-SpA cohort.

Arthritis care & research

de Jong HMY, de Winter JJH, van der Horst-Bruinsma IE, van Schaardenburg DJ, van Gaalen FA, van Tubergen AM, Weel AEAM, Landewé RBM, Baeten DLP, van de Sande MGH.
PMID: 34219406
Arthritis Care Res (Hoboken). 2021 Jul 05; doi: 10.1002/acr.24743. Epub 2021 Jul 05.

OBJECTIVES: As first-degree relatives (FDRs) of HLA-B27-positive axial spondyloarthritis (axSpA) patients have an increased risk of developing axSpA, the objectives were 1) to evaluate presence of highly specific imaging features as well as clinical signs of SpA at baseline...

Cite
de Jong HMY, de Winter JJH, van der Horst-Bruinsma IE, et al. Progression from subclinical inflammation to overt SpA in first degree relatives of SpA patients is associated with HLA-B27: the Pre-SpA cohort. Arthritis Care Res (Hoboken). 2021;doi: 10.1002/acr.24743.
de Jong, H. M. Y., de Winter, J. J. H., van der Horst-Bruinsma, I. E., van Schaardenburg, D. J., van Gaalen, F. A., van Tubergen, A. M., Weel, A. E. A. M., Landewé, R. B. M., Baeten, D. L. P., & van de Sande, M. G. H. (2021). Progression from subclinical inflammation to overt SpA in first degree relatives of SpA patients is associated with HLA-B27: the Pre-SpA cohort. Arthritis care & research, . https://doi.org/10.1002/acr.24743
de Jong, Henriëtte M Y, et al. "Progression from subclinical inflammation to overt SpA in first degree relatives of SpA patients is associated with HLA-B27: the Pre-SpA cohort." Arthritis care & research vol. (2021). doi: https://doi.org/10.1002/acr.24743
de Jong HMY, de Winter JJH, van der Horst-Bruinsma IE, van Schaardenburg DJ, van Gaalen FA, van Tubergen AM, Weel AEAM, Landewé RBM, Baeten DLP, van de Sande MGH. Progression from subclinical inflammation to overt SpA in first degree relatives of SpA patients is associated with HLA-B27: the Pre-SpA cohort. Arthritis Care Res (Hoboken). 2021 Jul 05; doi: 10.1002/acr.24743. Epub 2021 Jul 05. PMID: 34219406.
Copy Download .nbib Format: NLM
Evaluating the ASAS recommendations for early referral of axial spondyloarthritis in patients with chronic low back pain; is one parameter present sufficient for primary care practice?.

Annals of the rheumatic diseases

van Hoeven L, Koes BW, Hazes JM, Weel AE.
PMID: 26416898
Ann Rheum Dis. 2015 Dec;74(12):e68. doi: 10.1136/annrheumdis-2015-208547. Epub 2015 Sep 28.

No abstract available.

Cite
van Hoeven L, Koes BW, Hazes JM, et al. Evaluating the ASAS recommendations for early referral of axial spondyloarthritis in patients with chronic low back pain; is one parameter present sufficient for primary care practice?. Ann Rheum Dis. 2015;74(12):e68doi: 10.1136/annrheumdis-2015-208547.
van Hoeven, L., Koes, B. W., Hazes, J. M., & Weel, A. E. (2015). Evaluating the ASAS recommendations for early referral of axial spondyloarthritis in patients with chronic low back pain; is one parameter present sufficient for primary care practice?. Annals of the rheumatic diseases, 74(12), e68. https://doi.org/10.1136/annrheumdis-2015-208547
van Hoeven, L, et al. "Evaluating the ASAS recommendations for early referral of axial spondyloarthritis in patients with chronic low back pain; is one parameter present sufficient for primary care practice?." Annals of the rheumatic diseases vol. 74,12 (2015): e68. doi: https://doi.org/10.1136/annrheumdis-2015-208547
van Hoeven L, Koes BW, Hazes JM, Weel AE. Evaluating the ASAS recommendations for early referral of axial spondyloarthritis in patients with chronic low back pain; is one parameter present sufficient for primary care practice?. Ann Rheum Dis. 2015 Dec;74(12):e68. doi: 10.1136/annrheumdis-2015-208547. Epub 2015 Sep 28. PMID: 26416898.
Copy Download .nbib Format: NLM
Assessment of adherence to corticosteroids in asthma by drug monitoring or fractional exhaled nitric oxide: A literature review.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Alahmadi F, Peel A, Keevil B, Niven R, Fowler SJ.
PMID: 33190234
Clin Exp Allergy. 2021 Jan;51(1):49-62. doi: 10.1111/cea.13787. Epub 2020 Nov 27.

BACKGROUND: Although the efficacy of corticosteroid treatment in controlling asthma is widely accepted, its effectiveness is undermined by poor adherence. However, the optimal method for measuring adherence to asthma therapy remains unclear.OBJECTIVE: To perform a review of the literature...

Cite
Alahmadi F, Peel A, Keevil B, et al. Assessment of adherence to corticosteroids in asthma by drug monitoring or fractional exhaled nitric oxide: A literature review. Clin Exp Allergy. 2020;51(1):49-62doi: 10.1111/cea.13787.
Alahmadi, F., Peel, A., Keevil, B., Niven, R., & Fowler, S. J. (2021). Assessment of adherence to corticosteroids in asthma by drug monitoring or fractional exhaled nitric oxide: A literature review. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 51(1), 49-62. https://doi.org/10.1111/cea.13787
Alahmadi, Fahad, et al. "Assessment of adherence to corticosteroids in asthma by drug monitoring or fractional exhaled nitric oxide: A literature review." Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology vol. 51,1 (2021): 49-62. doi: https://doi.org/10.1111/cea.13787
Alahmadi F, Peel A, Keevil B, Niven R, Fowler SJ. Assessment of adherence to corticosteroids in asthma by drug monitoring or fractional exhaled nitric oxide: A literature review. Clin Exp Allergy. 2021 Jan;51(1):49-62. doi: 10.1111/cea.13787. Epub 2020 Nov 27. PMID: 33190234; PMCID: PMC7839457.
Copy Download .nbib Format: NLM
Showing 1 to 3 of 3 entries